News
Jason Mundin: “It was a simple idea, but the most complicated was to make it work”
Jason Mundin, MBA, Director of Collaborations at Population Genetics, gave a Knowledge and Technology Transfer seminar, presenting his company, last 25th July in IDIBELL. Population Genetics, created in 2005 by Dr Sydney Brenner, Nobel Laureate in Medicine, has developed novel sequencing approaches to identify variants in candidate genomic regions in populations ranging in size from […]
A bone scan tracks the process of osseointegration in dental implants
The study developed by researchers of the research group of the Odontological and Maxillofacial Pathology and Therapeutics at the Bellvitge Biomedical Research Institute (IDIBELL) and the University of Barcelona (UB) concludes that bone scintigraphy may be a suitable technique for monitoring the procedure in bone integration implants. The paper has been published in the June […]
Josep Manuel Menchón, appointed new Scientific Director of IDIBELL
The Board of Trustees of IDIBELL has appointed Josep Manuel Menchón as new Scientific Director of the centre. Dr. Menchón is a renowned physician and researcher in the field of psychiatry and mental health. The new Scientific Director will replace, from October 1st, Gabriel Capellá, who has held this position since 2009. The Board has […]
Alfons Nonell: ”the application of computer tools saves time and money to researcher”
The application of computing in science has increased dramatically in recent years to the point that it is becoming common to use computational tools to understand, plan and complete the experimental results obtained in the laboratory. Alfons Nonell is CEO of Mind the Byte, a company located on the campus of Bellvitge, in the bioincubator […]
Poisoning from industrial compounds can cause similar effects to ALS
Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) at the University of Barcelona (UB) have coordinated a research into how the IDPN nitrile causes neurological syndromes similar to those of the amyotrophic lateral sclerosis (ALS), a severe neuromuscular degenerative disease. The study, led by Jordi Llorens, has been recently published in Neuropathology and Applied Neurobiology […]
Grifols acquires 40% of the capital of biotechnology firm VCN Bioscience
Grifols the world’s third largest plasma product manufacturer and a pioneer in the research and development of therapeutic alternatives designed to contribute to both scientific and social development, has acquired 40% of the equity of Catalan biotechnology firm VCN Biosciences, dedicated to the research and development of new therapeutic approaches for tumors for which there […]
Barbara Marte, Nature editor: ”Now we are publishing more documents than ever”
Nature, first published on 1869, is the leading weekly, international scientific journal. Most scientific journals are now highly specialized, and Nature is among the few journals that still publish original research articles across a wide range of scientific fields. Nature is a private owned publication. The Nature Published Group (NPG) includes Nature, Nature Research Journals, […]
The activation of VRK1, new step in the response to DNA damage
Relationship between cancer and VRK1, a chromatin kinase implicated in DNA damage responses, related to neurodegenerative diseases. The group of Pedro A. Lazo, researcher at the Institute of Molecular and Cellular Biology of Cancer, from CSIC and the University of Salamanca, is investigating the role of VRK1 kinase in response to cell damage and how […]
Manel Esteller opens the First International Conference on Biology of Catalonia
The First International Conference of Biology of Catalonia joins more than eight hundred scientists from around the world The First International Conference on Biology of Catalonia, entitled “Global advanced questions on Biology,” will be opened with the conference “Epigenètica: de la biologia a la malaltia” by Manel Esteller, researcher at the Bellvitge Biomedical Research Institute […]